BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24212890)

  • 1. Bronchiolitis obliterans syndrome leads to a functional deterioration of the acinus post lung transplant.
    Thompson BR; Hodgson YM; Kotsimbos T; Liakakos P; Ellis MJ; Snell GI; Verbanck S
    Thorax; 2014 May; 69(5):487-8. PubMed ID: 24212890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early bronchiolitis obliterans syndrome shows an abnormality of perfusion not ventilation in lung transplant recipients.
    Thompson BR; Ellis MJ; Stuart-Andrews C; Lopez M; Kedarisetty S; Snell GI; Prisk GK
    Respir Physiol Neurobiol; 2015 Sep; 216():28-34. PubMed ID: 25981891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of forced expiratory volume in one second-fraction of the engrafted lung with 133-Xe radiospirometry improves the diagnosis of bronchiolitis obliterans syndrome in single lung transplant recipients.
    Ikonen T; Harjula AL; Kinnula VL; Savola J; Sovijärvi A
    J Heart Lung Transplant; 1995; 14(2):244-50. PubMed ID: 7779842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-lung transplantation bronchiolitis obliterans].
    Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
    Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
    Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring the lung periphery of transplanted lungs.
    Van Muylem A; Verbanck S; Estenne M
    Respir Physiol Neurobiol; 2005 Aug; 148(1-2):141-51. PubMed ID: 15963771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
    Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
    J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of bronchiolitis obliterans syndrome stage 0-p.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    Am J Respir Crit Care Med; 2004 Feb; 169(4):468-72. PubMed ID: 14670802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
    Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
    Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
    J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome.
    Ikonen T; Kivisaari L; Harjula AL; Lehtola A; Heikkilä L; Kinnula VL; Kyösola K; Savola J; Sipponen J; Verkkala K; Mattila SP
    J Heart Lung Transplant; 1996 Jun; 15(6):587-95. PubMed ID: 8803756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in basement membrane thickness in airway walls post-lung transplantation.
    Law L; Zheng L; Orsida B; Levvey B; Oto T; Kotsimbos AT; Snell GI; Williams TJ
    J Heart Lung Transplant; 2005 Oct; 24(10):1571-6. PubMed ID: 16210132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Dusmet M; Maurer J; Winton T; Kesten S
    J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
    Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
    PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bronchiolitis obliterans syndrome in lung transplant recipients].
    Antus B; Fillinger J; Csiszér E; Czebe K; Horváth I
    Orv Hetil; 2005 May; 146(19):953-8. PubMed ID: 15969307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.